254 related articles for article (PubMed ID: 20461661)
1. [Emergency management of acute angioedema].
Bas M; Greve J; Bier H; Knopf A; Stark T; Schuler P; Hoffmann TK; Kojda G
Dtsch Med Wochenschr; 2010 May; 135(20):1027-31. PubMed ID: 20461661
[TBL] [Abstract][Full Text] [Related]
2. Nonallergic angioedema: role of bradykinin.
Bas M; Adams V; Suvorava T; Niehues T; Hoffmann TK; Kojda G
Allergy; 2007 Aug; 62(8):842-56. PubMed ID: 17620062
[TBL] [Abstract][Full Text] [Related]
3. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
4. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?
Longhurst HJ
Int J Clin Pract; 2005 May; 59(5):594-9. PubMed ID: 15857357
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
Bork K; Frank J; Grundt B; Schlattmann P; Nussberger J; Kreuz W
J Allergy Clin Immunol; 2007 Jun; 119(6):1497-503. PubMed ID: 17418383
[TBL] [Abstract][Full Text] [Related]
6. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
Greve J; Hoffmann TK; Schuler P; Lang S; Chaker A; Bas M
Int J Dermatol; 2011 Oct; 50(10):1294-5. PubMed ID: 21950301
[TBL] [Abstract][Full Text] [Related]
7. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.
Zanichelli A; Bova M; Coerezza A; Petraroli A; Triggiani M; Cicardi M
Allergy; 2012 Aug; 67(8):1074-7. PubMed ID: 22686628
[TBL] [Abstract][Full Text] [Related]
8. [Management of bradykinin-mediated angioedema].
Floccard B; Crozon J; Rimmelé T; Vulliez A; Coppere B; Chamouard V; Boccon-Gibod I; Bouillet L; Allaouchiche B
Ann Fr Anesth Reanim; 2011; 30(7-8):578-88. PubMed ID: 21454034
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin-mediated angioedema.
Obtułowicz K
Pol Arch Med Wewn; 2016; 126(1-2):76-85. PubMed ID: 26842379
[TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
Lumry WR; Li HH; Levy RJ; Potter PC; Farkas H; Moldovan D; Riedl M; Li H; Craig T; Bloom BJ; Reshef A
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):529-37. PubMed ID: 22123383
[TBL] [Abstract][Full Text] [Related]
11. [Perioperative treatment of a patient with hereditary angioedema (HAE) in a case of a young patient with osteosynthesis from a femoral fracture].
Eckert S; Eifrig B; Standl T
Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Dec; 35(12):776-81. PubMed ID: 11194524
[TBL] [Abstract][Full Text] [Related]
12. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
Bartal C; Zeldetz V; Stavi V; Barski L
Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
14. Acute urticaria and angioedema: diagnostic and treatment considerations.
Frigas E; Park MA
Am J Clin Dermatol; 2009; 10(4):239-50. PubMed ID: 19489657
[TBL] [Abstract][Full Text] [Related]
15. The Incidence and Frequency of Various Causes of Angioedema in Emergency Medicine.
Karadža-Lapić L; Pikivaca T; Pervan P; Jović Zlatović J; Delin S; Prkačin I
Acta Med Acad; 2018 May; 47(1):11-17. PubMed ID: 29957967
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and management of angioedema of the head and neck.
Bas M; Hoffmann TK; Kojda G
Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):170-5. PubMed ID: 16728895
[TBL] [Abstract][Full Text] [Related]
17. Hereditary angioedema: an update on available therapeutic options.
Maurer M; Magerl M
J Dtsch Dermatol Ges; 2010 Sep; 8(9):663-72. PubMed ID: 20602665
[TBL] [Abstract][Full Text] [Related]
18. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Bas M; Bier H; Greve J; Kojda G; Hoffmann TK
Allergy; 2006 Dec; 61(12):1490-2. PubMed ID: 17073887
[No Abstract] [Full Text] [Related]
19. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
20. [Increasing incidence of angioedema without urticaria--clinical features].
Marković AS; Janzeković M
Acta Med Croatica; 2011; 65(2):119-27. PubMed ID: 22359877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
